UCSD, Isis Pharmaceuticals enter CRISPR gene editing race
Isis Pharmaceuticals has teamed up with UCSD to demonstrate a commercially feasible way to use RNA to control CRISPR gene editing.
Medicare and beneficiary $103B spending on drugs in 2013 detailed, Isis Pharmaceuticals gets $10M from Biogen (Morning Read)
TOP STORIES The federal government detailed drug spending, detailing doctor-by-doctor and drug-by-drug how Medicare and its beneficiaries spent $103 billion on pharmaceuticals in 2013. Isis Pharmaceuticals, Inc. announced it has earned a $10 million milestone payment from Biogen associated with the validation of an undisclosed target to treat a neurological disorder. LIFE SCIENCE Italian biotech […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.